D-Glutamate

D-Glutamate

SCHEMBL2853218

N[C@@H](CCC(=O)[O-])C(=O)[O-].[K+].[Na+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of D-Glutamate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.50
FOLH1 Q04609 3/20 0.42
BBOX1 O75936 1/20 0.40
CA2 P00918 2/20 0.39
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GSR P00390 1/20 0.39
CYP1A2 P05177 1/20 0.39
GRIK1 P39086 1/20 0.39
GRM5 P41594 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
GRIA4 P48058 1/20 0.39
GRIN1 Q05586 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL2853212 1.00 CA1 (0.50) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL28385660 0.98 CA1 (0.48) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL541429 0.98 CA1 (0.52) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL18880 0.98 CA1 (0.52) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL82750 0.98 CA1 (0.48) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL23611029 0.98 CA1 (0.48) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL330961 0.98 CA1 (0.52) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL16335 0.98 CA1 (0.52) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL82753 0.98 CA1 (0.48) CA1FOLH1BBOX1CA2GRM8
D-Glutamate SCHEMBL7068284 0.98 CA1 (0.48) CA1FOLH1BBOX1CA2GRM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118715314-A Production of colored fungal mycelia 玛仕莱布斯有限公司 2024-09-27 CN disclosed
CN-112125821-B Aqueous solution containing N-long-chain acyl acidic amino acid and/or salt thereof and method for producing same 味之素株式会社 2024-02-20 CN disclosed
CN-114762742-A Extracorporeal blood medication system 张勇 2022-07-19 CN disclosed
EP-0843818-B2 LAWSONIA INTRACELLULARIS CULTIVATION, ANTI-LAWSONIA INTRACELLULARIS VACCINES AND DIAGNOSTIC AGENTS BOEHRINGER INGELHEIM VETMEDICA INC (US) 2018-12-19 EP disclosed
EP-1403643-B2 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents BOEHRINGER INGELHEIM VETMEDICA INC (US) 2018-10-03 EP disclosed
EP-2199795-B1 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents BOEHRINGER INGELHEIM VETMED (US) 2016-03-30 EP disclosed
EP-1645567-B2 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents BOEHRINGER INGELHEIM VETMED (US) 2016-01-06 EP disclosed
CN-104800841-A Inactivated vaccine for abortion chlamydia of yaks and preparation method of inactivated vaccine LANZHOU VETERINARY RES INST CAAS 2015-07-29 CN disclosed
EP-1655607-B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents BOEHRINGER INGELHEIM VETMED (US) 2015-05-13 EP disclosed
CN-1519311-B Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents NOBL LAB INC 2013-03-13 CN disclosed
EP-0843818-B1 LAWSONIA INTRACELLULARIS CULTIVATION, ANTI-LAWSONIA INTRACELLULARIS VACCINES AND DIAGNOSTIC AGENTS BOEHRINGER INGELHEIM VETMED (US) 2005-02-09 EP disclosed
CN-1519311-A Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents 诺博实验室股份有限公司 2004-08-11 CN disclosed
EP-1403643-A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents Boehringer Ingelheim Vetmedica, Inc. (US) 2004-03-31 EP disclosed
EP-0843818-A4 LAWSONIA INTRACELLULARIS CULTIVATION, ANTI-LAWSONIA INTRACELLULARIS VACCINES AND DIAGNOSTIC AGENTS BOEHRINGER INGELHEIM NOBL LAB (US) 2002-02-06 EP disclosed
US-5885823-A BACTERIA STRAIN ATCC NO.55783 ARE INCUBATED IN AN OXYGEN CONCENTRATION OF FROM ABOUT 0 PERCENT TO ABOUT 18 PERCENT, AGITATING THE BACTERIA IN SUSPENSION; VETERINARY MEDICINE NOBL LABORATORIES, INC. (US) 1999-03-23 US disclosed
EP-0843818-A1 LAWSONIA INTRACELLULARIS CULTIVATION, ANTI-LAWSONIA INTRACELLULARIS VACCINES AND DIAGNOSTIC AGENTS Boehringer Ingelheim/Nobl Laboratories, Inc. (US) 1998-05-27 EP disclosed
CN-1181898-A Gourmet powder XIE YONG (CN) 1998-05-20 CN disclosed
US-5714375-A INCUBATING INFECTED CELLS IN A REDUCED OXYGEN CONCENTRATION AND MAINTAINING INFECTED CELL IN SUSPENSION BY AGITATION FOR PREFERENTIAL TIME TO INCREASE THE PRODUCTION, AND CULTURING AT LEAST A PORTION OF THE BACTERIA NOBL LABORATORIES, INC. (US) 1998-02-03 US disclosed
CN-1167146-A Lawsonia intracellularis culture, vaccine and diagnostic reagent against the same NOBL LAB INC (US) 1997-12-10 CN disclosed
WO-1996039629-A1 LAWSONIA INTRACELLULARIS CULTIVATION, ANTI-LAWSONIA INTRACELLULARIS VACCINES AND DIAGNOSTIC AGENTS BOEHRINGER INGELHEIM/NOBL LABORATORIES, INC. (US) 1996-12-12 WO disclosed